scanance.
Sign inGet Premium
DO

Doximity, Inc.

DOCSHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$644.9M
+13.1% YoY
Net Income
$196.1M
-12.2% YoY
EBITDA
$229.3M
-4.8% YoY
Free Cash Flow
$255.3M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About Doximity, Inc.

Doximity, Inc. operates a digital platform for medical professionals in the United States. The $3.85B market capitalization puts DOCS squarely in mid-cap range for its industry. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems.

Key stats
Market Cap$3.85B
P/E (TTM)21.50
Fwd P/E13.21
EPS$0.98
Beta1.35
52W Change-59.6%
ROE19.3%
Analysis

With $748.6M in cash and $10.2M in debt, DOCS maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $255.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 19.3% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 11.6% further supports the picture of efficient asset utilization. Revenue has grown from $419.1M (2023) to $644.9M (2026), reflecting a 54% increase over the period.

With cash comfortably exceeding debt, DOCS has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Doximity, Inc. and its sector.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms